BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24177261)

  • 21. Endocrine effects of chemicals: aspects of hazard identification and human health risk assessment.
    Dekant W; Colnot T
    Toxicol Lett; 2013 Dec; 223(3):280-6. PubMed ID: 23542818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human exposure to endocrine disrupting compounds: Their role in reproductive systems, metabolic syndrome and breast cancer. A review.
    Giulivo M; Lopez de Alda M; Capri E; Barceló D
    Environ Res; 2016 Nov; 151():251-264. PubMed ID: 27504873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Informatics Approach to Evaluating Combined Chemical Exposures from Consumer Products: A Case Study of Asthma-Associated Chemicals and Potential Endocrine Disruptors.
    Gabb HA; Blake C
    Environ Health Perspect; 2016 Aug; 124(8):1155-65. PubMed ID: 26955064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS).
    Melching-Kollmuss S; Bothe K; Charlton A; Gangadharan B; Ghaffari R; Jacobi S; Marty S; Marxfeld HA; McInnes EF; Sauer UG; Sheets LP; Strupp C; Tinwell H; Wiemann C; Botham PA; van Ravenzwaay B
    Crit Rev Toxicol; 2023 Jul; 53(6):339-371. PubMed ID: 37554099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The concept of endocrine disruption and human health].
    Cravedi JP; Zalko D; Savouret JF; Menuet A; Jégou B
    Med Sci (Paris); 2007 Feb; 23(2):198-204. PubMed ID: 17291431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early neuroendocrine disruption in hypothalamus and hippocampus: developmental effects including female sexual maturation and implications for endocrine disrupting chemical screening.
    Bourguignon JP; Franssen D; Gérard A; Janssen S; Pinson A; Naveau E; Parent AS
    J Neuroendocrinol; 2013 Nov; 25(11):1079-87. PubMed ID: 24028442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
    Yilmaz B; Terekeci H; Sandal S; Kelestimur F
    Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of endocrine disruptor chemicals in gynaecology.
    Caserta D; Maranghi L; Mantovani A; Marci R; Maranghi F; Moscarini M
    Hum Reprod Update; 2008; 14(1):59-72. PubMed ID: 18070835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound.
    Lagadic L; Katsiadaki I; Biever R; Guiney PD; Karouna-Renier N; Schwarz T; Meador JP
    Rev Environ Contam Toxicol; 2018; 245():65-127. PubMed ID: 29119384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is an endocrine disruptor?
    Monneret C
    C R Biol; 2017; 340(9-10):403-405. PubMed ID: 29126512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental non-persistent endocrine-disrupting chemicals exposure and reproductive hormones levels in adult men.
    Dziewirska E; Hanke W; Jurewicz J
    Int J Occup Med Environ Health; 2018 Oct; 31(5):551-573. PubMed ID: 30228382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
    Dogan S; Simsek T
    Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Endocrine Disrupting Effects in Rats Perinatally Exposed to Butylparaben.
    Boberg J; Axelstad M; Svingen T; Mandrup K; Christiansen S; Vinggaard AM; Hass U
    Toxicol Sci; 2016 Jul; 152(1):244-56. PubMed ID: 27122241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Report from the BfR expert hearing on practicability of hormonal measurements: recommendations for experimental design of toxicological studies with integrated hormonal end points.
    Kucheryavenko O; Lurman G; Lehmann A; Braz J; Niemann L; Chahoud I; Mantovani A; Håkansson H; Schneider S; Strauss V; Coder PS; Freyberger A; O'Connor JC; Rauch M; Renko K; Solano MLM; Andersson N; Blanck O; Ritz V; Solecki R
    Arch Toxicol; 2019 Apr; 93(4):1157-1167. PubMed ID: 30929029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Union's strategy on endocrine disrupting chemicals and the current position of Slovenia.
    Perharič L; Fatur T; Drofenik J
    Arh Hig Rada Toksikol; 2016 Jun; 67(2):99-105. PubMed ID: 27331297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of rat testis development following combined in utero exposure to the phytoestrogen genistein and antiandrogenic plasticizer di-(2-ethylhexyl) phthalate.
    Jones S; Boisvert A; Duong TB; Francois S; Thrane P; Culty M
    Biol Reprod; 2014 Sep; 91(3):64. PubMed ID: 25031359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine disrupting chemicals: effects on human male reproductive health.
    Murray TJ; Lea RG; Abramovich DR; Haites NE; Fowler PA
    Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):80-112. PubMed ID: 11753523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP toxicity report of reproductive dose range-finding study of Genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats.
    Delclos KB; Newbold R
    Toxic Rep Ser; 2007 Nov; (79):1-C2. PubMed ID: 18685712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In utero exposure to the oestrogen mimic diethylstilbestrol disrupts gonadal development in a viviparous reptile.
    Parsley LM; Wapstra E; Jones SM
    Reprod Fertil Dev; 2015 Sep; 27(7):1106-14. PubMed ID: 24718097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human exposure to endocrine disruptors and breast milk.
    Stefanidou M; Maravelias C; Spiliopoulou C
    Endocr Metab Immune Disord Drug Targets; 2009 Sep; 9(3):269-76. PubMed ID: 19594415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.